Comparison of effectiveness of injection vitamin D3 with normal saline in patients suffering from warts
Phase 2
- Conditions
- Health Condition 1: B079- Viral wart, unspecified
- Registration Number
- CTRI/2022/10/046217
- Lead Sponsor
- IPGMER and SSKMH
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Adult patients with multiple warts who are willing to participate in the study through an informed consent.
Exclusion Criteria
Patients with multiple warts not willing to participate in the study.
Patients with single wart.
Pregnant and lactating patients with multiple warts.
Patients with multiple warts but aged <18years.
Immunocompromised patients with multiple warts.
Patients with mucosal, facial or anogenital warts.
Patients with severe cardiac or respiratory comorbidities.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Reduction in number and size of the local and distant warts.Timepoint: Baseline, 4 week, 8 week, 12 week, 16 week, 20 week, 24 week, 28 week, 32 week
- Secondary Outcome Measures
Name Time Method ilTimepoint: Nil